Gland Pharma Quarterly Results for Trading Insights

GLAND • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹184 Cr
QSept 2025
Quarterly Results

Gland Pharma Quarterly Results Key Highlights

  • Revenue of ₹1,571 Cr in Sept 2025 (+6.9% vs Mar 2025, +7.2% vs Sept 2024)
  • Net Profit of ₹184 Cr in Sept 2025 (-1.6% vs Mar 2025, +12.2% vs Sept 2024)
  • EBITDA of ₹398 Cr in Sept 2025 (+1.5% vs Mar 2025)
  • Operating Margin of 21.0% in Sept 2025 (-3.0pp vs Mar 2025)
  • Earnings Per Share of ₹11.15 in Sept 2025 (-1.5% vs Mar 2025)

Gland Pharma Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 1,571 1,469 1,563 1,759 1,466 6.9% 7.2%
Net Profit (₹ Cr) 184 187 216 262 164 - -
EBITDA (₹ Cr) 398 392 425 474 357 - -
EPS (₹) 11.15 11.32 13.08 15.87 9.93 - -
Operating Margin (%) 21.0% 24.0% 24.0% 24.0% 21.0% - -

Gland Pharma Share Price Trend Around Quarterly Results

Visualize Gland Pharma's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Gland Pharma

Additional stock information and data for GLAND

GLAND stock overview
GLAND P/E comparison
Gland Pharma 52-week

Profitability Ratios

Profit Margin 11.7%
EBITDA Margin 25.3%
Operating Margin 21.0%
ROE (Annual) 8.0%

Balance Sheet Highlights

Total Assets ₹11,225 Cr
Total Equity ₹9,151 Cr
Current Assets ₹6,783 Cr
Current Liabilities ₹509 Cr

Cash Flow Analysis

Operating Cash Flow ₹915 Cr
Investing Cash Flow ₹1,718 Cr
Financing Cash Flow ₹-434 Cr
Net Cash Flow ₹2,199 Cr

Current Market Data

Current Price ₹1716.40
Exchange NSE
Last Updated Apr 07, 2026

Revenue Trend (₹ Cr)

Dec 2025 1,759
Jun 2025 1,563
Mar 2025 1,469
Sept 2025 1,571

Net Profit Trend (₹ Cr)

Dec 2025 262
Jun 2025 216
Mar 2025 187
Sept 2025 184

Operating Margin Trend (%)

Dec 2025 24.0%
Jun 2025 24.0%
Mar 2025 24.0%
Sept 2025 21.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Gland Pharma quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1718.0 14,875 3,125 +10.8% - 21.0% 132.2
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5850.0 2,860 689 +7.1% - 24.1% 225.3
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4051.3 3,219 591 +11.3% - 18.4% 231.0
Lupin
Sept 2025 		₹102,578.78 Cr 2298.3 6,921 1,485 +23.2% - 21.5% 71.0
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1196.1 9,135 1,337 +1.1% - 14.6% 73.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores